Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)

Recruiting

Conditions: Pediatric Hydrocephalus

First Posted Date: 2008-05-02

Last Posted Date: 2024-12-18

Lead Sponsor: University of Utah

Target Recruit Count: 1400

Registration Number: NCT00670735

Locations: 🇺🇸
Children's Hospital of Alabama, University of Alabama, Birmingham, Alabama, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

and more 11 locations

Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Drug: Copper T380 IUD
Drug: levonorgestrel

First Posted Date: 2008-04-30

Last Posted Date: 2014-12-22

Lead Sponsor: University of Utah

Target Recruit Count: 57

Registration Number: NCT00669396

Locations: 🇺🇸
Planned Parenthood Association of Utah, West Valley City Clinic, West Valley City, Utah, United States

Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors

Not Applicable

Completed

Conditions: Hyperglycemia
Hypertension
Dyslipidemia

Interventions: Dietary Supplement: Xocai Activ drink

First Posted Date: 2008-04-24

Last Posted Date: 2016-02-08

Lead Sponsor: University of Utah

Target Recruit Count: 10

Registration Number: NCT00666250

Locations: 🇺🇸
Cardiovascular Genetics, University of Utah, Salt Lake City, Utah, United States

Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Resistance Exercise via Negative Eccentric Work
Behavioral: Standard care exercise training

First Posted Date: 2008-04-23

Last Posted Date: 2011-09-21

Lead Sponsor: University of Utah

Target Recruit Count: 41

Registration Number: NCT00665184

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States

CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I

Phase 1

Completed

Conditions: Spinal Muscular Atrophy Type I

Interventions: Drug: Valproic Acid and Levocarnitine

First Posted Date: 2008-04-18

Last Posted Date: 2015-06-15

Lead Sponsor: University of Utah

Target Recruit Count: 40

Registration Number: NCT00661453

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Children's Hospital of Michigan, Detroit, Michigan, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

and more 5 locations

Comparison of Humidified High Flow Nasal Cannula to Nasal CPAP in Neonates

Not Applicable

Completed

Conditions: Respiratory Insufficiency

Interventions: Other: Nasal CPAP
Other: Humidified High Flow Nasal Cannula (HHFNC)

First Posted Date: 2008-02-07

Last Posted Date: 2013-02-06

Lead Sponsor: University of Utah

Target Recruit Count: 420

Registration Number: NCT00609882

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Wilford Hall Medical Center, Lackland AFB, Texas, United States
🇺🇸
McKay-Dee Medical Center, Ogden, Utah, United States

and more 6 locations

Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients

Phase 2

Terminated

Conditions: Solid Tumors
Cancer Brain
Gastrointestinal Stromal Tumors

Interventions: Drug: Peginterferon-alpha 2b (PegIFNa2b);
Drug: Imatinib

First Posted Date: 2008-01-03

Last Posted Date: 2017-02-10

Lead Sponsor: University of Utah

Target Recruit Count: 8

Registration Number: NCT00585221

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Effects of Vitamin D on Renin Expression in Hypertensive Patients

Early Phase 1

Terminated

Conditions: Hypertension
Vitamin D Deficiency

Interventions: Drug: calcitriol
Drug: Placebo

First Posted Date: 2008-01-03

Last Posted Date: 2016-05-27

Lead Sponsor: University of Utah

Target Recruit Count: 12

Registration Number: NCT00585442

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer

Phase 2

Completed

Conditions: Cancer

Interventions: Drug: Bevacizumab and Erlotinib

First Posted Date: 2008-01-03

Last Posted Date: 2015-09-24

Lead Sponsor: University of Utah

Target Recruit Count: 50

Registration Number: NCT00585377

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT

Phase 4

Completed

Conditions: Obesity
Venous Thrombosis
Anticoagulants

Interventions: Drug: Enoxaparin 0.5 mg/kg once daily

First Posted Date: 2008-01-03

Last Posted Date: 2018-04-05

Lead Sponsor: University of Utah

Target Recruit Count: 28

Registration Number: NCT00585182

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy